<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02760732</url>
  </required_header>
  <id_info>
    <org_study_id>301_xnk1</org_study_id>
    <nct_id>NCT02760732</nct_id>
  </id_info>
  <brief_title>Drug Eluting Balloon for Treatment of Unstable Angina</brief_title>
  <official_title>Drug Eluting Balloon Combined With Cutting Balloon for Treatment of Unstable Angina</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yun Dai Chen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese PLA General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study was to investigate the effect and safety of drug eluting balloon combined for
      treatment of unstable angina.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with unstable angina were randomized to drug eluting stent only or drug eluting
      balloon group. Angiographic follow-up was performed after 12 months. The primary endpoints
      were late lumen loss (LLL) and the secondary endpoints were target lesion revascularization
      (TLR),and the major adverse cardiovascular events (MACE) .
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Anticipated">August 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in Target Lumen assessed by optical coherence tomography</measure>
    <time_frame>12 months</time_frame>
    <description>A coronary de novo lesion in patient after intervened was measured with optical coherence tomography .To measure the changes in target lumen at 12 months.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence rate of MACE</measure>
    <time_frame>Incidence rate of MACE from baseline to 12 months</time_frame>
    <description>MACE include composite of death, myocardial infarction, or target-vessel revascularization</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Angina, Unstable</condition>
  <arm_group>
    <arm_group_label>drug eluting balloon group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients with unstable angina were randomised to drug eluting balloon group for percutaneous transluminal coronary angioplasty with a strategy of cutting balloon(Flextome Cutting Balloon, Boston Scientific Corporation, US) pre-dilation first and then drug eluting balloon(Sequent please; B. Braun, Melsungen, Germany) .</description>
  </arm_group>
  <arm_group>
    <arm_group_label>drug eluting stent group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients with unstable angina were randomised to this group for drug eluting stent (YINYI® Polymer-free Drug-coated (Paclitaxel) Coronary Stent System, Liaoning Biomedical Materials R&amp;D Center Co., Ltd. China) implantation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>drug eluting balloon; cutting balloon</intervention_name>
    <description>Patients eligible for inclusion criteria were randomised to study group for percutaneous transluminal coronary angioplasty with a strategy of cutting balloon pre-dilation first and then drug eluting balloon.</description>
    <arm_group_label>drug eluting balloon group</arm_group_label>
    <other_name>Sequent please; B. Braun; Flextome Cutting Balloon, Boston Scientific</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>drug eluting stent</intervention_name>
    <description>with a strategy of drug-eluting stent implantation alone for de novo coronary artery lesions.</description>
    <arm_group_label>drug eluting stent group</arm_group_label>
    <other_name>YINYI®</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients &gt; 18, &lt; 80 years old, with unstable angina

          -  Single-vessel or double-vessel disease

          -  Length of target lesion &lt; 25mm

          -  Diameter of target vessel &gt;2.5mm, &lt; 3.5mm

        Exclusion Criteria:

          -  Left main disease

          -  Chronic total occlusion

          -  Severe Tortuosity

          -  Heavy calcification

          -  Severe liver failure, moderate or severe kidney failure

          -  Malignant disease

          -  Active infectious disease

          -  Pregnancy or breastfeeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>CHEN YUN DAI, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The General Hospital of PLA</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>LI BO, MD</last_name>
    <phone>+8601055499309</phone>
    <email>22401919@qq.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The General Hospital of PLA</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100853</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>LI BO, MD</last_name>
      <phone>+8601055499309</phone>
      <email>22401919@QQ.COM</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 29, 2016</study_first_submitted>
  <study_first_submitted_qc>April 30, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 4, 2016</study_first_posted>
  <last_update_submitted>November 28, 2017</last_update_submitted>
  <last_update_submitted_qc>November 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Chinese PLA General Hospital</investigator_affiliation>
    <investigator_full_name>Yun Dai Chen</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Angina Pectoris</mesh_term>
    <mesh_term>Angina, Unstable</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

